On May 15, 2023, the U.S. Supreme Court denied two highly watched petitions for certiorari, refusing to hear cases that dealt with the patent eligible subject matter requirement of 35 U.S.C. § 101.
The Supreme Court’s...more
In its July 5, 2016 decision in Rapid Litigation Management Ltd and In Vitro, Inc. v. CellzDirect, Inc. and Invitrogen Corp., the Federal Circuit held that patent claims directed to an improved method of cryopreserving...more
7/9/2016
/ Ariosa ,
Biotechnology ,
CLS Bank v Alice Corp ,
Examiners ,
Life Sciences ,
Mayo v. Prometheus ,
Method Claims ,
Obviousness ,
Patent-Eligible Subject Matter ,
Patents ,
Petition for Writ of Certiorari ,
Reversal ,
Section 101 ,
Sequenom ,
Summary Judgment ,
USPTO